(19)
(11) EP 1 751 178 A2

(12)

(88) Date of publication A3:
16.03.2006

(43) Date of publication:
14.02.2007 Bulletin 2007/07

(21) Application number: 05750800.4

(22) Date of filing: 03.06.2005
(51) International Patent Classification (IPC): 
C07K 14/165(2006.01)
C07K 16/10(2006.01)
G01N 33/569(2006.01)
A61K 48/00(2006.01)
A61K 39/215(2006.01)
C12Q 1/70(2006.01)
A61K 39/42(2006.01)
(86) International application number:
PCT/EP2005/006512
(87) International publication number:
WO 2005/118813 (15.12.2005 Gazette 2005/50)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 04.06.2004 US 860641
10.06.2004 US 578348 P

(71) Applicants:
  • INSTITUT PASTEUR
    75724 Paris Cédex 15 (FR)
  • HKU - Pasteur Research Centre Limited
    Hong Kong (CN)

(72) Inventors:
  • ALTMEYER, Ralf
    Hong Kong (CN)
  • NAL-ROGIER, Béatrice
    Jade Garden-Mid Levels Hong Kong (CN)
  • CHAN, Cheman
    Provident Center-North Point Hong Kong (CN)
  • KIEN, François
    Hong Kong (CN)
  • KAM, Yiu, Wing
    Hong Kong (CN)
  • SIU, Yu, Lam
    Chai Wan Hong Kong (CN)
  • TSE, Kong, San
    Hong Kong (CN)
  • STAROPOLI, Isabelle
    F-75014 Paris (FR)
  • MANUGUERRA, Jean-Claude
    F-75018 Paris (FR)

(74) Representative: Desaix, Anne et al
Ernest Gutmann - Yves Plasseraud S.A.S. 3, rue Auber
75009 Paris
75009 Paris (FR)

   


(54) NUCLEIC ACIDS, POLYPEPTIDES, METHODS OF EXPRESSION, AND IMMUNOGENIC COMPOSITIONS ASSOCIATED WITH SARS CORONA VIRUS SPIKE PROTEIN